TABLE 3.
Median values and interquartile ranges of dosimetric parameters for our cohort of 200 left‐sided patients.
Dose constraints | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
PTV | Heart | Ipsilateral lung | Contralateral breast | ||||||||
Strategy | V95 (%) | V90 (%) | D max(%) | D5% (cGy) | V8Gy (%) | D med (cGy) | V16Gy (%) | V8Gy (%) | V4Gy (%) | D max (cGy) | |
G1OpS1 | Median (IQR) | 92.75 (6.55) | 95.50 (4.06) | 106.20 (1.20) | 823.37 (825.47) | 5.09 (4.08) | 294.19 (82.81) | 11.60 (5.16) | 16.18 (5.80) | 27.06 (8.61) | 1249.16 (3320.23) |
G1OpS2 | Median (IQR) | 92.58 (7.11) | 95.52 (3.97) | 106.34 (1.18) | 666.79 (572.19) | 4.49 (2.63) | 282.98 (59.66) | 11.14 (4.97) | 15.55 (5.36) | 26.64 (8.01) | 757.54 (2224.52) |
G1OpS3 | Median (IQR) | 92.96 (6.68) | 95.61 (3.88) | 106.52 (1.19) | 704.53 (707.63) | 4.66 (3.24) | 288.12 (71.86) | 11.34 (5.13) | 15.72 (5.60) | 26.84 (7.99) | 792.64 (2381.97) |
G2OpS1 | Median (IQR) | 96.19 (4.31) | 99.04 (1.62) | 106.08 (1.12) | 1062.39 (487.95) | 6.83 (4.08) | 294.71 (65.09) | 12.12 (4.35) | 18.75 (5.02) | 31.58 (7.95) | 667.25 (2697.09) |
G2OpS2 | Median (IQR) | 95.74 (4.86) | 98.87 (1.74) | 106.26 (1.27) | 782.89 (328.15) | 4.90 (1.80) | 270.98 (31.62) | 11.83 (3.80) | 17.89 (4.56) | 30.18 (7.49) | 510.97 (1538.56) |
G2OpS3 | Median (IQR) | 96.08 (4.70) | 98.90 (1.85) | 106.39 (1.39) | 826.15 (396.18) | 5.12 (2.00) | 276.21 (41.65) | 11.96 (4.15) | 18.28 (4.99) | 30.31 (7.63) | 521.63 (1707.61) |
G3OpS1 | Median (IQR) | 96.21 (4.06) | 98.97 (1.62) | 106.28 (1.34) | 1042.49 (314.79) | 7.68 (4.50) | 309.84 (57.53) | 12.31 (3.77) | 19.60 (5.63) | 39.12 (11.92) | 536.94 (2425.78) |
G3OpS2 | Median (IQR) | 95.64 (4.49) | 98.74 (1.81) | 106.44 (1.55) | 768.04 (242.66) | 4.81 (1.51) | 267.67 (24.64) | 12.02 (3.35) | 18.89 (4.90) | 35.65 (11.93) | 451.83 (1361.69) |
G3OpS3 | Median (IQR) | 95.98 (4.23) | 98.81 (1.91) | 106.64 (1.58) | 799.64 (300.20) | 5.00 (1.69) | 271.88 (32.35) | 12.13 (3.62) | 18.71 (4.86) | 35.22 (11.75) | 481.29 (1599.15) |